Company Overview
About Emerald Cloud Lab
Emerald Cloud Lab (ECL) is a biotechnology infrastructure company that enables scientists to conduct real wet-lab experiments entirely remotely through a cloud-based interface. Founded as a spin-out of Emerald Therapeutics, ECL operates physical laboratories stocked with over 200 instrument models — including liquid handlers, mass spectrometers, and genomics tools — that researchers control through its unified Command Center software. Scientists can design, execute, and analyze experiments without ever entering a physical lab, democratizing access to advanced instrumentation that would otherwise require millions in capital expenditure.
Business Model & Competitive Advantage
ECL reached approximately $15M in annual revenue by late 2025 and employs roughly 167 people across facilities in North America and Europe, including new labs in Austin, Texas and Pittsburgh, Pennsylvania. A notable milestone was ECL''s collaboration with CMU researchers to develop Coscientist, an AI system powered by GPT-4 that can autonomously design and execute chemistry experiments using ECL''s platform. ECL also open-sourced its Symbolic Lab Language (SLL), a domain-specific programming language for specifying scientific protocols, reinforcing its role as an infrastructure layer for the life sciences.
Competitive Landscape 2025–2026
ECL''s model is particularly valuable for academic researchers, biotech startups, and pharmaceutical companies that need rapid experimental throughput without the capital burden of in-house labs. As AI-driven drug discovery accelerates demand for high-throughput experimentation, ECL sits at the intersection of lab automation, cloud software, and autonomous science — a differentiated position in an underserved segment of life sciences infrastructure.
Key Differentiators
Strong Challenger
Emerald Cloud Lab is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Similar Brands
Cradle
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, acti
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Compare Emerald Cloud Lab with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Emerald Cloud Lab? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Emerald Cloud Lab Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Emerald Cloud Lab vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →